Dr. Brett Patrick Blake, MD

Dr. Blake practices at Gardens Plastic Surgery in Cape Coral, Florida.

Dr. Blake's NPI, 1376772707, was assigned on July 7, 2009. Dr. Blake graduated from USF Health Morsani College of Medicine in 2009. Dr. Blake holds Florida license ME125767.

Dr. Blake's primary practice is Gardens Plastic Surgery, at 413 Del Prado S Blvd, Cape Coral, FL 33990 in Lee County. The practice phone is (239) 313-2515.

Dr. Blake's primary practice is Gardens Plastic Surgery in Cape Coral, Florida. The medical group on file is Suncoast Skin Solutions. Dmand AI also links Dr. Blake to 2 more group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Blake practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Blake's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Blake is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Blake's licenses on file in 3 states: Florida, Virginia and Rhode Island.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, hives, itchy rashes and minor head injury among the conditions Dr. Blake treats.

CMS data shows 4,536 Medicare services from Dr. Blake across 28 procedure codes in 2024, for 936 Medicare patients. Medicare paid $488,988 for them. Every service was in an office.

CMS counts 936 Medicare patients who saw Dr. Blake in 2024. The largest group is 75 to 84, with 442 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 1% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Blake's median patient age at 78, with 45% women.

In 2024, Dr. Blake wrote 935 Medicare Part D claims for 504 patients. 93% of them were for generic drugs. CMS names the drug for 776 of them, across 16 drugs with 11 or more claims each, at $172,817 in total drug cost. In 2023, CMS named 747 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Blake for performance year 2024, reported as part of a group. Dr. Blake accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 125 procedures of melanoma (skin cancer) excision by Dr. Blake, more than 95% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Blake in 2013. The most frequent topics are Mohs Surgery, Surgical Flaps and Patient Satisfaction. Dr. Blake has published most often in Dermatol Surg. Dr. Blake's most frequent co-authors are Ian A. Maher, MD, Basil S. Cherpelis, MD and Tracy A. Novosel, MD.

CMS Open Payments shows 75 general payments to Dr. Blake from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Abbvie Inc. paid the most, $426.

Dr. Blake graduated from USF Health Morsani College of Medicine in 2009. Dr. Blake is a member of AAD, American College of Mohs Surgery and ASDS.

Dr. Blake is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.